GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Navamedic ASA (OSL:NAVA) » Definitions » Piotroski F-Score

Navamedic ASA (OSL:NAVA) Piotroski F-Score : 3 (As of May. 28, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Navamedic ASA Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Navamedic ASA has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Navamedic ASA's Piotroski F-Score or its related term are showing as below:

OSL:NAVA' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 4   Max: 7
Current: 3

During the past 13 years, the highest Piotroski F-Score of Navamedic ASA was 7. The lowest was 3. And the median was 4.


Navamedic ASA Piotroski F-Score Historical Data

The historical data trend for Navamedic ASA's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navamedic ASA Piotroski F-Score Chart

Navamedic ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 5.00 4.00 7.00 3.00

Navamedic ASA Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.00 - 7.00 - 3.00

Competitive Comparison of Navamedic ASA's Piotroski F-Score

For the Medical Distribution subindustry, Navamedic ASA's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Navamedic ASA's Piotroski F-Score Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Navamedic ASA's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Navamedic ASA's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was kr3.3 Mil.
Cash Flow from Operations was kr2.2 Mil.
Revenue was kr512.0 Mil.
Gross Profit was kr199.1 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (382.773 + 524.305) / 2 = kr453.539 Mil.
Total Assets at the begining of this year (Dec22) was kr382.8 Mil.
Long-Term Debt & Capital Lease Obligation was kr103.4 Mil.
Total Current Assets was kr210.1 Mil.
Total Current Liabilities was kr189.3 Mil.
Net Income was kr29.4 Mil.

Revenue was kr382.1 Mil.
Gross Profit was kr163.5 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (330.179 + 382.773) / 2 = kr356.476 Mil.
Total Assets at the begining of last year (Dec21) was kr330.2 Mil.
Long-Term Debt & Capital Lease Obligation was kr47.0 Mil.
Total Current Assets was kr243.5 Mil.
Total Current Liabilities was kr126.1 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Navamedic ASA's current Net Income (TTM) was 3.3. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Navamedic ASA's current Cash Flow from Operations (TTM) was 2.2. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=3.304/382.773
=0.00863175

ROA (Last Year)=Net Income/Total Assets (Dec21)
=29.432/330.179
=0.08913953

Navamedic ASA's return on assets of this year was 0.00863175. Navamedic ASA's return on assets of last year was 0.08913953. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Navamedic ASA's current Net Income (TTM) was 3.3. Navamedic ASA's current Cash Flow from Operations (TTM) was 2.2. ==> 2.2 <= 3.3 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=103.359/453.539
=0.2278944

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=46.991/356.476
=0.13182094

Navamedic ASA's gearing of this year was 0.2278944. Navamedic ASA's gearing of last year was 0.13182094. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=210.118/189.283
=1.11007328

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=243.54/126.061
=1.93192185

Navamedic ASA's current ratio of this year was 1.11007328. Navamedic ASA's current ratio of last year was 1.93192185. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Navamedic ASA's number of shares in issue this year was 17.574. Navamedic ASA's number of shares in issue last year was 17.023. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=199.053/511.997
=0.38877767

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=163.52/382.135
=0.4279116

Navamedic ASA's gross margin of this year was 0.38877767. Navamedic ASA's gross margin of last year was 0.4279116. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=511.997/382.773
=1.33759957

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=382.135/330.179
=1.15735707

Navamedic ASA's asset turnover of this year was 1.33759957. Navamedic ASA's asset turnover of last year was 1.15735707. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+0+0+0+0+0+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Navamedic ASA has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Navamedic ASA  (OSL:NAVA) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Navamedic ASA Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Navamedic ASA's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Navamedic ASA (OSL:NAVA) Business Description

Traded in Other Exchanges
Address
Henrik Ibsensgate 100, Solli Plass, Lysaker, NOR, N-0255
Navamedic ASA is a pharmaceutical company that operates in a single segment, which is marketing, selling, and distributing pharmaceuticals and medical nutrition products to hospitals, pharmacies, and patients, bought from product suppliers and manufacturers in Europe and other places. Its product categories include Medical nutrition, Consumer health, Branded generics, and Specialty pharma.

Navamedic ASA (OSL:NAVA) Headlines

No Headlines